Tirzepatide ntụ ntụ maka ịgbanye maka mbelata ibu 30mg kwa Vial ọcha 99%

Tirzepatide bụ akwụkwọ akụkọ, na-eme glucose na-adabere insulinotropic polypeptide (GIP) na glucagon-dị ka peptide-1 (GLP-1) agonist nnabata. Ọ na-anọchi anya ọganihu dị ịrịba ama na ọgwụgwọ ụdị ọrịa shuga 2 ma gosipụta nsonaazụ na-ekwe nkwa na njikwa ibu. Tirzepatide ntụ ntụ ntụ bụ ụdị ọgwụ eji akwadebe ihe ngwọta maka nchịkwa subcutaneous.

Usoro nke Omume
Tirzepatide na-arụ ọrụ site na ịgbalite ma GIP na GLP-1 ndị na-anabata ya, nke na-etinye aka n'ịhazi ọkwa shuga ọbara na agụụ. Agonism nke abụọ na-enye ọtụtụ uru bara uru:

Ihe nzuzo insulin na-abawanye: Ọ na-akpali mwepụta insulin n'ụzọ dabere na glucose, na-enyere aka iwetu ọkwa shuga dị n'ọbara n'emeghị hypoglycemia.
Mwepụta Glucagon egbochiri: Ọ na-ebelata mpụta nke glucagon, homonụ na-ebuli ọkwa shuga dị n'ọbara.
Iwu agụụ: Ọ na-akwalite satiety ma na-ebelata iri nri, na-enye aka na mbelata ibu.
Ịwụfu afọ ntachi nke afọ: Ọ na-egbu oge ịwụsa afọ, nke na-enyere aka ịchịkwa spikes ọbara shuga postprandial.

Ekwenyere iji
N'ime mmelite kachasị ọhụrụ, ndị ọrụ nchịkwa dị ka US Food and Drug Administration (FDA) akwadoro Tirzepatide maka ọgwụgwọ ụdị ọrịa shuga 2. A na-enyochakwa ya maka enwere ike iji ya na njikwa oke ibu.

Uru
Njikwa Glycemic dị irè: Mbelata dị ukwuu na ọkwa HbA1c.
Mbelata ibu: Mbelata oke ibu, nke bara uru maka ndị ọrịa nwere ụdị ọrịa shuga 2 na oke ibu.
Uru Cardiovascular: Enwere ike imeziwanye ihe ize ndụ nke obi, ọ bụ ezie na ọmụmụ ihe na-aga n'ihu na-enyocha akụkụ a ọzọ.
Mma: Dosing otu ugboro kwa izu na-eme ka nrube isi nke onye ọrịa ma e jiri ya tụnyere ọgwụ kwa ụbọchị.

Mmetụta nwere ike ime
Ọ bụ ezie na a na-anabatakarị Tirzepatide nke ọma, ụfọdụ ndị ọrụ nwere ike nweta mmetụta dị n'akụkụ, gụnyere:

Nsogbu eriri afọ:

Ọgbụgbọ, ọgbụgbọ, afọ ọsịsa, na afọ ntachi na-adịkarị, karịsịa n'oge mmalite nke ọgwụgwọ.
Ihe ize ndụ nke hypoglycemia: karịsịa mgbe ejiri ya na ọgwụ ndị ọzọ na-ebelata glucose.
Pancreatitis: ọ dị obere mana ọ dị njọ, na-achọ nlekọta ahụike ozugbo ma ọ bụrụ na mgbaàmà dịka oke mgbu afọ na-eme.

Nkwadebe na nchịkwa
Tirzepatide ntụ ntụ kwesịrị ka e megharịa ya na ihe mgbaze kwesịrị ekwesị (na-enyekarị na kit) iji mepụta ngwọta maka ịgba ọgwụ. Ngwọta edozigharịrị kwesịrị ịdị ọcha na enweghị uru. A na-enye ya subcutaneously n'ime afọ, apata ụkwụ, ma ọ bụ ogwe aka elu.